Kuros Biosciences, a leader in next-generation bone graft technologies, provides an update on its commercial activities for the first nine months of 2023 and announces changes and a transition in responsibilities within the Executive Management.
Kuros Biosciences, a leader in next-generation bone graft technologies, provides an update on its commercial activities for the first nine months of 2023 and announces changes and a transition in responsibilities within the Executive Management.